Neuroendocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
Search for other papers by Nidan Qiao in
Google Scholar
PubMed
bias and confounding are not the main question of interest in machine learning studies. How to assess the quality of these studies remains unsolved, and a reporting guideline was not available for these studies to follow. This review presents a quality
Search for other papers by Régis Coutant in
Google Scholar
PubMed
Pediatric team of the Clinical Investigation Center 9302/INSERM, Hospital of Children, Toulouse, France
Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291 - CNRS UMR5051 - Université Toulouse III, Toulouse, France
Search for other papers by Maithé Tauber in
Google Scholar
PubMed
Search for other papers by Béatrice Demaret in
Google Scholar
PubMed
Search for other papers by Robin Henocque in
Google Scholar
PubMed
Search for other papers by Yves Brault in
Google Scholar
PubMed
Search for other papers by François Montestruc in
Google Scholar
PubMed
Patient-Reported Outcomes Unit (PROQOL), UMR 1123, University Paris Cité, INSERM, Paris, France
Search for other papers by Olivier Chassany in
Google Scholar
PubMed
Search for other papers by Michel Polak in
Google Scholar
PubMed
Search for other papers by the QOLITHOR Study Group in
Google Scholar
PubMed
improvement of psychosocial problems ( 3 , 4 ) and improvement in quality of life (QOL) ( 5 , 6 ). In addition, rhGH injections are well tolerated ( 7 , 8 ) even if adherence to treatment was shown as suboptimal ( 9 ). The majority of currently available
Search for other papers by Yukari Maki in
Google Scholar
PubMed
Search for other papers by Kiyomi Horiuchi in
Google Scholar
PubMed
Search for other papers by Takahiro Okamoto in
Google Scholar
PubMed
treatment, such as quality of life or psychological burden, are essential concerns for cancer survivors ( 6 , 7 ). Besides, labelling people with diagnoses may itself could be harmful to psychological well-being ( 8 , 9 ). Some thoughtful clinicians may
Search for other papers by Sebastian Franik in
Google Scholar
PubMed
Search for other papers by Kathrin Fleischer in
Google Scholar
PubMed
Search for other papers by Barbara Kortmann in
Google Scholar
PubMed
Search for other papers by Nike M Stikkelbroeck in
Google Scholar
PubMed
Search for other papers by Kathleen D’Hauwers in
Google Scholar
PubMed
Search for other papers by Claire Bouvattier in
Google Scholar
PubMed
Search for other papers by Jolanta Slowikowska-Hilczer in
Google Scholar
PubMed
Search for other papers by Solange Grunenwald in
Google Scholar
PubMed
Search for other papers by Tim van de Grift in
Google Scholar
PubMed
Search for other papers by Audrey Cartault in
Google Scholar
PubMed
Search for other papers by Annette Richter-Unruh in
Google Scholar
PubMed
Search for other papers by Nicole Reisch in
Google Scholar
PubMed
Search for other papers by Ute Thyen in
Google Scholar
PubMed
Search for other papers by Joanna IntHout in
Google Scholar
PubMed
Search for other papers by Hedi L Claahsen-van der Grinten in
Google Scholar
PubMed
Search for other papers by the dsd-LIFE group in
Google Scholar
PubMed
interventions and accommodations. Men with KS may also face discrimination due to the absence of inclusive policies, accommodations, or resources that address their unique needs. However, little is known about the quality of life (QOL) in men with KS
Search for other papers by Julie Wulf Christensen in
Google Scholar
PubMed
Search for other papers by Karin Folmer Thøgersen in
Google Scholar
PubMed
Search for other papers by Lars Thorbjørn Jensen in
Google Scholar
PubMed
Department of Clinical Physiology and Nuclear Medicine, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark
Search for other papers by Martin Krakauer in
Google Scholar
PubMed
Search for other papers by Bent Kristensen in
Google Scholar
PubMed
Search for other papers by Finn Noe Bennedbæk in
Google Scholar
PubMed
Search for other papers by Bo Zerahn in
Google Scholar
PubMed
quality of life (QoL). To easily evaluate self-reported QoL, RAND Health Care (Santa Monica, CA, USA) has developed a 36-item short form health survey (SF-36) ( 6 ). The SF-36 questionnaire comprises 36 questions divided into 8 sections. The score from
Department of Hematology, University of Groningen, University Medical Center Groningen, The Netherlands
Search for other papers by Hanneke J C M Wouters in
Google Scholar
PubMed
Search for other papers by Bruce H R Wolffenbuttel in
Google Scholar
PubMed
Search for other papers by Anneke C Muller Kobold in
Google Scholar
PubMed
Search for other papers by Thera P Links in
Google Scholar
PubMed
Search for other papers by Gerwin Huls in
Google Scholar
PubMed
Search for other papers by Melanie M van der Klauw in
Google Scholar
PubMed
guidelines. In general, treatment is aimed at abolishing complaints related to hypothyroidism, and normalizing plasma thyroid stimulating hormone (TSH) levels ( 1 ). However, it has been shown that health-related quality of life (HRQoL) improves after 6
Search for other papers by Elizabeth J de Koster in
Google Scholar
PubMed
Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands
Division of Clinical Studies, Institute of Cancer Research, London, UK
Search for other papers by Olga Husson in
Google Scholar
PubMed
Search for other papers by Eveline W C M van Dam in
Google Scholar
PubMed
Search for other papers by G Sophie Mijnhout in
Google Scholar
PubMed
Search for other papers by Romana T Netea-Maier in
Google Scholar
PubMed
Department of Radiology and Nuclear Medicine, Rijnstate Hospital, Arnhem, The Netherlands
Department of Biomedical Sciences and Humanitas Clinical and Research Centre, Department of Nuclear Medicine, Humanitas University, Milan, Italy
Search for other papers by Wim J G Oyen in
Google Scholar
PubMed
Search for other papers by Marieke Snel in
Google Scholar
PubMed
Department of Radiology, Section of Nuclear Medicine, Leiden University Medical Center, Leiden, The Netherlands
Biomedical Photonic Imaging Group, University of Twente, Enschede, The Netherlands
Search for other papers by Lioe-Fee de Geus-Oei in
Google Scholar
PubMed
Search for other papers by Dennis Vriens in
Google Scholar
PubMed
Search for other papers by for the EfFECTS trial study group in
Google Scholar
PubMed
-effective in a Dutch setting, with lower societal lifelong costs while maintaining the long-term health-related quality of life (HRQoL) in patients undergoing FDG-PET/CT-driven management as compared to routine diagnostic surgery or molecular testing ( 8 , 9
Parathyroid Unit – LIM-28, Laboratório de Cirurgia de Cabeça e Pescoço, Division of Head and Neck Surgery, Department of Surgery, Hospital das Clinicas (HCFMUSP), University of São Paulo School of Medicine (FMUSP), Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil
Search for other papers by Marília D’Elboux Guimarães Brescia in
Google Scholar
PubMed
Endocrine Oncology Division, Institute of Cancer of the State of São Paulo (ICESP), University of São Paulo School of Medicine (FMUSP), Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, São Paulo, Brazil
Search for other papers by Karine Candido Rodrigues in
Google Scholar
PubMed
Search for other papers by André Fernandes d’Alessandro in
Google Scholar
PubMed
Search for other papers by Wellington Alves Filho in
Google Scholar
PubMed
Search for other papers by Willemijn Y van der Plas in
Google Scholar
PubMed
Search for other papers by Schelto Kruijff in
Google Scholar
PubMed
Search for other papers by Sergio Samir Arap in
Google Scholar
PubMed
Search for other papers by Sergio Pereira de Almeida Toledo in
Google Scholar
PubMed
Search for other papers by Fábio Luiz de Menezes Montenegro in
Google Scholar
PubMed
Endocrine Oncology Division, Institute of Cancer of the State of São Paulo (ICESP), University of São Paulo School of Medicine (FMUSP), Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, São Paulo, Brazil
Search for other papers by Delmar Muniz Lourenço Jr in
Google Scholar
PubMed
/anatomical difficulties or limited healthy parathyroid tissue available. As HYPO is expected to be associated with lower quality of life (QoL), either by its symptoms or by the treatment of hypocalcemia ( 17 ), the extent of the surgical procedure and its ideal timing
Department of Endocrinology, Trondheim University Hospital (St Olavs Hospital), Trondheim, Norway
Search for other papers by Unni Syversen in
Google Scholar
PubMed
Medical Clinic, Trondheim University Hospital (St Olavs Hospital), Trondheim, Norway
Search for other papers by Mats Peder Mosti in
Google Scholar
PubMed
Search for other papers by Ida Maria Mynarek in
Google Scholar
PubMed
Search for other papers by Trude Seselie Jahr Vedal in
Google Scholar
PubMed
Department of Gastroenterology, Trondheim University Hospital (St Olavs Hospital), Trondheim, Norway
Search for other papers by Kristin Aasarød in
Google Scholar
PubMed
Search for other papers by Trude Basso in
Google Scholar
PubMed
Search for other papers by Janne E Reseland in
Google Scholar
PubMed
Search for other papers by Per Medbøe Thorsby in
Google Scholar
PubMed
K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, NTNU, Trondheim, Norway
Search for other papers by Bjorn O Asvold in
Google Scholar
PubMed
Search for other papers by Erik Fink Eriksen in
Google Scholar
PubMed
Medical Clinic, Trondheim University Hospital (St Olavs Hospital), Trondheim, Norway
Search for other papers by Astrid Kamilla Stunes in
Google Scholar
PubMed
fracture risk is higher than the small reduction in BMD ( 4 ). BMD gives an estimation of bone quantity but provides little information about bone quality, which encompasses the structural and material properties of bone ( 5 ). Bone material properties are
Search for other papers by A J Varewijck in
Google Scholar
PubMed
Search for other papers by A J van der Lely in
Google Scholar
PubMed
Search for other papers by S J C M M Neggers in
Google Scholar
PubMed
Search for other papers by S W J Lamberts in
Google Scholar
PubMed
Search for other papers by L J Hofland in
Google Scholar
PubMed
Search for other papers by J A M J L Janssen in
Google Scholar
PubMed
, 9) . Previously, we found that determination of IGF1 bioactivity may offer advantages in the evaluation of adult GH deficiency compared with total IGF1 (10) . In another study, we found that IGF1 bioactivity reflects different aspects of quality of